GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.6863
+0.0407 (6.30%)
At close: Aug 24, 2026, 4:00 PM EDT
0.6711
-0.0152 (-2.21%)
After-hours: Aug 24, 2026, 7:47 PM EDT
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $5.06 million as of August 24, 2026. Its market cap has decreased by -73.96% in one year.
Market Cap
5.06M
Enterprise Value
2.24M
1-Year Change
-73.96%
Ranking
Category
Stock Price
$0.69
ChartMarket Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $5.06M, an increase of 2,008.35%. That is a compound annual growth rate of 55.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 5.06M | -31.14% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 5.46M |
| PMGC Holdings | 5.39M |
| BioAtla | 5.30M |
| Addex Therapeutics | 5.21M |
| Aptevo Therapeutics | 4.83M |
| Jupiter Neurosciences | 4.77M |
| Alaunos Therapeutics | 4.47M |
| Mustang Bio | 4.38M |